(Q35017801)

5 August 2017

1 reference

title

Molecular genotyping of hepatitis B virus (English)

1 reference

5 August 2017

1 reference

1 reference

Berwyn Clarke

1

1 reference

5 August 2017

Stuart Bloor

series ordinal

2

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Journal of Clinical Virology

5 August 2017

published in

1 reference

5 August 2017

volume

25 Suppl 3

1 reference

5 August 2017

page(s)

S41-5

1 reference

Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Hepatitis B virus genotypes and hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Typing of hepatitis B virus genomes by a simplified polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Relationships between serotypes and genotypes of hepatitis B virus: genetic classification of HBV by use of surface genes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900193-2

7 January 2021

10.1016/S1386-6532(02)00193-2

Identifiers

DOI

1 reference

5 August 2017

1 reference